NAPROXEN SODIUM IN THE TREATMENT OF MIGRAINE

被引:72
作者
JOHNSON, ES
RATCLIFFE, DM
WILKINSON, M
机构
关键词
D O I
10.1046/j.1468-2982.1985.0501005.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:5 / 10
页数:6
相关论文
共 8 条
[1]   PROSTAGLANDIN SYNTHETASE-ACTIVITY FROM HUMAN RHEUMATOID SYNOVIAL MICROSOMES - EFFECT OF ASPIRIN-LIKE DRUG-THERAPY [J].
CROOK, D ;
COLLINS, AJ ;
BACON, PA ;
CHAN, R .
ANNALS OF THE RHEUMATIC DISEASES, 1976, 35 (04) :327-332
[2]  
FRANCIULLACCI M, 1972, RES CLIN STUD HEADAC, V3, P335
[3]  
LANCE JW, 1973, MECHANISM MANAGEMENT
[4]   EFFECT OF NAPROXEN AND OF ASPIRIN ON BLEEDING-TIME AND PLATELET-AGGREGATION [J].
NADELL, J ;
BRUNO, J ;
VARADY, J ;
SEGRE, EJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 14 (04) :176-182
[5]   EFFECT OF SULPHINPYRAZONE ON HUMAN-PLATELET AGGREGATION, 5-HYDROXYTRYPTAMINE RELEASE AND ADHESION EXVIVO - COMPARISON WITH NAPROXEN [J].
NUNN, B ;
JAMES, FJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (03) :239-245
[6]  
OLESEN J, 1981, LANCET, V2, P438
[7]   BIOAVAILABILITY OF NAPROXEN SODIUM AND ITS RELATIONSHIP TO CLINICAL ANALGESIC EFFECTS [J].
SEVELIUS, H ;
RUNKEL, R ;
SEGRE, E ;
BLOOMFIELD, SS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (03) :259-263
[8]   CLINICAL TRIAL OF A NEW ANTI-BRADYKININ, ANTIINFLAMMATORY DRUG, KETOPROFEN (19.583 RP) IN MIGRAINE PROPHYLAXIS [J].
STENSRUD, P ;
SJAASTAD, O .
HEADACHE, 1974, 14 (02) :96-100